期刊文献+

siRNA干扰人BMP9重组腺病毒载体的构建及其促进乳腺癌SK-BR-3细胞增殖 被引量:4

Construction of recombinant adenovirus vector interfering the expression of human BMP9 and promoting the proliferation of breast cancer SK-BR-3 cells
下载PDF
导出
摘要 目的筛选特异性干扰人BMP9基因的siRNA序列并制备重组腺病毒AdsiBMP9,探讨RNAi人BMP9基因后对乳腺癌SK-BR-3细胞增殖能力的影响。方法设计制备3对干扰人BMP9的双链DNA序列,亚克隆至Pses-Hus质粒中获得Pses-Hus-siBMP9质粒,脂质体转染乳腺上皮细胞HBL-100筛选有效干扰质粒,构建重组腺病毒并感染SK-BR-3细胞,RT-PCR,Western blot检测BMP9表达,MTT检测细胞增殖能力。结果成功构建并筛选出针对人BMP9基因的有效干扰质粒并包装成腺病毒,病毒滴度为1×1010IU/mL,感染SK-BR-3细胞显示BMP9在转录水平和翻译水平表达量显著低于对照组和空白组(P<0.05),第5天AdsiBMP9组细胞的增殖率显著高于AdsiNC组(P<0.05)。结论成功构建特异性沉默人BMP9基因的siRNA腺病毒载体,可有效抑制SK-BR-3细胞中BMP9基因的表达从而促进该细胞增殖。 Objective To screen specific small interfering RNA(siRNA) target human BMP9 gene and to prepare recombinant adenovirus vector AdsiBMP9 for investigation of its effects on the proliferation of breast cancer SK-BR- 3cells. Methods Three pairs of double-stranded DNA fragments for silencing human BMP9 were designed and synthesized, then subcloned into the shuttle plasmid Pses-Hus. The recombinant plasmids Pses-Hus-siBMP9 were transfected into the breast epithelial cells HBL-100 by lipofectamine transfection reagent, screened the effective in- terfering plasmid, constructed AdsiBMP9 and infected SK-BR-3 cells. The expression level of BMP9 mRNA and protein were detected by RT-PCR and western blot. The proliferation of SK-BR-3 cells were observed with MTY assay. Results The recombinant plasmid Pses-Hus-siBMP9 and recombinant adenovirus AdsiBMP9 were success- fully constructed and its titer was 1 × 1010IU/mL. Compared to the negative and non-infected controls, the expres-sion of BMP9 gene was significantly inhibited after the SK-BR-3 cells were infected by AdsiBMP9. SK-BR-3 cells infected with AdsiBMP9 showed a promotive effect. On the fifth day, the growth rate of experiment groups was sig- nificantly higher than that of negative groups. Conclusions Specific siRNA targeting human BMP9 gene was suc- cessfully constructed, which can effectively inhibit endogenous expression of BMP9 in SK-BR-3cells and promote its proliferation.
出处 《基础医学与临床》 CSCD 北大核心 2013年第2期149-155,共7页 Basic and Clinical Medicine
基金 国家自然科学基金(81172017 30800658)
关键词 SIRNA 人BMP9 重组腺病毒载体 肿瘤增殖 siRNA human BMP9 recombinant adenovirus vector tumor proliferation
  • 相关文献

参考文献12

  • 1Davies SR, Watkins G, Douglas-Jones A, et al. Bone mor- phogenetic proteins 1 to 7 in human breast cancer, expres- sion pattern and clinical/prognostic relevance [ J ]. J Exp 3"her Oncol, 2008,7 : 327 - 338.
  • 2冯红蕾,王科,孙笑笑,罗进勇,张彦.骨形态发生蛋白9对人乳腺癌MDA-MB-231细胞增殖与凋亡的作用研究[J].重庆医科大学学报,2010,35(11):1619-1623. 被引量:4
  • 3王科,冯红蕾,孙笑笑,罗进勇,张彦.骨形态发生蛋白9抑制人乳腺癌MDA-MB-231细胞体外侵袭和迁移[J].基础医学与临床,2011,31(4):360-365. 被引量:9
  • 4David L, Mallet C, Keramidas M, et al. Bone morphoge- netic protein-9 is a circulating vascular quiescence factor[J]. Circ Res, 2008, 102:914-922.
  • 5Ye L, Bokobza SM, Jiang WG. Bone morphogenetic pro- teins in development and progression of breast cancer and therapeutic potential[J]. Int J Mol Med, 2009,24:591 - 597.
  • 6Scharpfenecker M, van Dinther M, Liu Z, et al. BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis [ J ]. J Cell Sci, 2007, 120:964 -972.
  • 7Alarmoo EL, Korhonen T, Kuukasjarvi T, et al. Bone mor- phogenetic protein 7 expression associates with bone metas- tasis in breast carcinomas [J]. Ann Oncol, 2008, 19: 308 - 314.
  • 8Herrera B, van Dinther M, Ten Dijke P, et al. Autocrine bone morphogenetie protein-9 signals through activin recep- tor-like kinase-2/Smadl/Smad4 to promote ovarian cancer.cell proliferation [ J ]. Cancer Res, 2009, 24 : 9254 - 9262.
  • 9Ye L, Kynaston H, Jiang WG. Bone morphogenetie pro- tein-9 induces apoptosis in prostate cancer cell, the role of prostate apoptosis response-4 [J]. Mol Cancer Res, 2008, 6 : 1594 - 1606.
  • 10毕杨,文巍,何昀,冯涛.骨形成发生蛋白9的siRNA筛选及功能检测[J].南方医科大学学报,2010,30(4):659-663. 被引量:1

二级参考文献64

  • 1Miyazawa K, Shinozaki M, Hara T, et al. Two major Smad pathways in TGF-b superfamily signaling [J]. Genes Cells, 2002, 7: 1191-204.
  • 2Luu HH, Song WX, Luo X, et al. Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem Cells [J]. J Orthop Res, 2007, 25(5): 665-77.
  • 3Song JJ, Celeste AJ, Kong FM, et al. Bone morphogenetic protein-9 binds to liver cells and stimulates proliferation [J ]. Endocrinology, 1995, 136: 4293-7.
  • 4Lopez-Coviella I, Berse B, Krauss R, et al. Induction and maintenance of the neuronal cholinergic phenotype in the central nervous system by BMP-9 [ J ]. Science, 2000, 289:313-6.
  • 5Elbashir SM, Lendeckel W, Tuschi T. RNA interference is mediated by 21- and 22-nucleotide RNAs[J]. Genes Dev, 2001, 15: 188-200.
  • 6David L, Mallet C, Keramidas M, et al. Bone morphogenetic protein-9 is a circulating vascular quiescence factor [J]. Circ Res, 2008, 102(8): 914-22.
  • 7Lopez-Coviella I, Follettie MT, Mellott T J, et al. Bone morphogenetic protein 9 induces the transcriptome of basal forebrain cholinergic neurons [J]. Proc Natl Acad Sci USA, 2005, 102(19): 6984-9.
  • 8Breitkopf K, Mtiller A, Ciuclan L, et al. Bone morphogenetic protein (BMP)-9: A new member of the TGF-[3 superfamily .which is secreted by activated by hepatic stellate cells [ J ]. J Hepatol, 2009, 50(S1): S110.
  • 9Miller AF, Harvey SA, Thies RS, et al. Bone morphogenetic protein-9. An autocrine/paracrine cytokine in the liver [J]. J Biol Chem, 2000, 275(24): 17937-45.
  • 10Chen C, Grzegorzewski K J, Barash S, et al. An integrated functional genomics screening program reveals a role for BMP-9 in glucose homeostasis [ J ]. Nat Biotechnol, 2003, 21 (3): 294-301.

共引文献15

同被引文献96

  • 1Tsai CC,Chen YJ, Yew TT、et al. Hypoxia inhibits senes-cence and maintains mesenchymal stem cell propertiesthrough down-regulation of E2A-p21 by HIF-TWIST [ J]Blood, 2011 , 117: 459-469.
  • 2Wagegg M, Gaber T, Lohanatha FT: et al. Hypoxia pro-motes osteogenesis but suppresses adipogenesis of humanmesenchymal stromal cells in a hypoxia-inducible factor-1dependent manner [ J] PloS One, 2012, 7 : e46483. doi :10. 1371/journal, pone. 0046483.
  • 3Geng YJ. Molecular mechanisms for cardiovascular stemcell apoptosis and growth in the hearts with atheroscleroticcoronary disease and ischemic heart failure [ J] Ann NYAcad Sci, 2003,1010:687 -697.
  • 4Zhu W, Chen J, Cong X,et al. Hypoxia and serum depri-vation-induced apoptosis in mesenchymal stem cells [ J]Stem Cells, 2006,24:416-425.
  • 5Li xueyuan, Zhang yang, Qi guoxian. Evaluation of isola-tion methods and culture conditions for rat bone marrowmesenchymal stem cells [ J] Cytotechnology, 2013 , 65 :323 -334. doi: 10.1007/sl0616-012-9497-3.
  • 6Abdallah BM, Haack-S0rensen M , Burns J S, ei al. Main-tenance of differentiation potential of human bone marrowmesenchymal stem cells immortalized by human telomerasereverse transcriptase gene despite of extensive proliferation[J] Biochem Biophy Res Commun, 2005,326 :527 -538.
  • 7Zhang SB, Xu YM, Wang B, et al. Cationic compoundsused in lipoplexes and polyplexes for gene delivery [ J] JControl Release, 2004,100: 165 -180.
  • 8Nicolazzi C,Garinot M, Mignet N, et al. Cationic lipids fortransfection [J] Curr Med Chem, 2003,10: 1263 - 1277.
  • 9Zandi E, Chen Y, Karin M. Direct phosphorylation of IkBby TKKa and IKKp: discrimination between free and NF-KB-bound substrate[ J] Science, 1998 ,281 : 1360 - 1363.
  • 10May MJ, D’Acquisto,F, Madge LA ,et al. Selective inhi-bition of NF-kB activation by a peptide that blocks the in-teraction of NEMO with the IkB kinase complex [ J] Sci-ence, 2000,289 : 1550 - 1554.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部